Clinical Trial Update: Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Toddlers [Phase 3]

View source ↗

Summary

Phase 3 trial update on the immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine in toddlers has completed with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningitis
• Meningococcal Infections

Drugs mentioned

• Investigational quadrivalent meningococcal conjugate vaccine

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Meningitis, Meningococcal Meningitis | Phase 3 | Status: COMPLETED | Results posted: 2020-06-09